Physician profile
Jason Dodder
NPI 1790744951
$5,442.06
in general payments reported to CMS, 2019-2025
19 companies · $445 in 2025
The $445 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,635 · 2020: $380 · 2021: $1,214 · 2022: $1,037 · 2023: $318 · 2024: $413 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,175.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,572.56 | 2019-2025 | 7 X 23mm Citrelock Implant, Citrefix, Easyfuse |
| Pylant Medical | $1,255.01 | 2021-2025 | |
| Nvision Biomedical Technologies, INC. | $906.73 | 2022 | |
| Djo, LLC | $419.06 | 2019 | |
| Medtronic, INC. | $363.50 | 2024 | Intellis Adaptivestim |
| Paragon 28, INC. | $289.46 | 2025 | Portfolio |
| Organogenesis INC. | $126.63 | 2021-2022 | |
| Smith+Nephew, INC. | $114.37 | 2019-2025 | Collagenase Santyl, Grafix Pl, Stravix Pl |
| Rikco International, LLC | $110.04 | 2019 | |
| Orthofix Medical, INC. | $45.22 | 2019 | |
| Bioventus LLC | $44.37 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $36.11 | 2023 | Qutenza |
| Kerecis Limited | $30.77 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Innovation Technologies INC | $27.00 | 2023 | Irrisept |
| Depuy Synthes Sales INC. | $26.91 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $23.76 | 2020 | |
| Nevro Corp. | $17.85 | 2022 | |
| Mimedx Group, INC. | $16.85 | 2025 | |
| Alafair Biosciences, INC. | $15.86 | 2025 | Versawrap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Dodder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.